封面
市場調查報告書
商品編碼
2052424

生物製藥物流市場:按類型、服務類型、應用和地區分類

Bio Pharma Logistics Market, By Type, By Service Type, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,生物製藥物流市場規模將達到1,215.2億美元,2033年將達到2,293.8億美元。預計從2026年到2033年,該市場將以9.5%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 1215.2億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 9.50% 2033年市場規模預測: 2293.8億美元

生物製藥物流是指安全、有效率地運輸、儲存和配送藥品和生物製藥。該領域在醫療產業中發揮著至關重要的作用,確保藥物和疫苗以最佳狀態送達指定。隨著全球對藥品需求的持續成長,生物製藥物流已成為供應鏈不可或缺的一部分,需要專門的基礎設施和專業技術。

市場動態:

生物製藥物流市場受多種因素驅動。首先,慢性病盛行率的上升以及對個人化醫療日益成長的需求,導致製藥研發活動激增。因此,藥品和生物製藥的生產和分銷量不斷增加,進而對高效的物流解決方案提出了更高的要求。

另一方面,市場也存在一些挑戰。藥品運輸和儲存,特別是需要低溫運輸管理的藥品,受到嚴格的監管要求,這構成了一項重大限制。雖然遵守這些法規對於維護產品完整性和保障病人安全至關重要,但這也增加了物流流程的複雜性和成本。

然而,這個市場也蘊藏著巨大的機會。物聯網和區塊鏈等技術在醫藥運輸追蹤溯源領域的日益普及,提高了供應鏈的透明度和完整性。這使得對溫度敏感型產品進行即時監控成為可能,從而降低劣化風險,確保產品品質。此外,蓬勃發展的電子商務產業也為醫藥分銷開闢了新的管道,為生物製藥物流供應商創造了潛在的市場。

本研究的主要特點:

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 針對全球生物製藥物流市場的主要參與者,我們根據公司概況、產品系列、主要亮點、財務表現和策略等參數創建了公司簡介。
  • 本次調查涵蓋的主要公司包括 DHL、FedEx、UPS、DB Schenker、Kuehne + Nagel、順豐速運、嘉里物流、Agility Logistics、VersaCold Logistics Services、Marken、加拿大航空貨運、CEVA Logistics、Sofrigam、Nordic Coldfrigam、Biocair、聯合服務公司、CaBioel、Bond Courier。
  • 本報告中的見解將使企業負責人和經營團隊能夠就產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球生物製藥物流市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等各產業相關人員。
  • 相關人員可以利用全球生物製藥物流市場分析中使用的各種策略矩陣來促進決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
      • 低溫運輸物流解決方案的技術進步
    • 抑制因子
      • 物流服務相關的高成本
    • 機會
      • 進入新興市場
  • 主要亮點
  • 監管趨勢
  • 近期趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購和合作

第4章:生物製藥物流市場:依類型分類,2021-2033年

  • 低溫運輸物流
  • 非低溫運輸物流

第5章:生物製藥物流市場:依服務類型分類,2021-2033年

  • 運輸
  • 倉儲
  • 包裝
  • 其他

第6章:生物製藥物流市場:依應用領域分類,2021-2033年

  • 生物製藥
  • 處方藥
  • 非處方藥
  • 原料藥及原料藥
  • 其他

第7章 生物製藥物流市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • DHL
  • FedEx
  • UPS
  • DB Schenker
  • Kuehne+Nagel
  • SF Express
  • Kerry Logistics
  • Agility Logistics
  • VersaCold Logistics Services
  • Marken
  • Air Canada Cargo
  • CEVA Logistics
  • Sofrigam
  • Nordic Cold Storage
  • Biocair
  • United Parcel Service
  • Cavalier Logistics
  • LifeConEx
  • AirBridgeCargo Airlines
  • World Courier

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6278

Bio-pharma Logistics Market is estimated to be valued at USD 121.52 Bn in 2026 and is expected to reach USD 229.38 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 121.52 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.50% 2033 Value Projection: USD 229.38 Bn

Bio-pharma logistics refers to the transportation, storage, and distribution of pharmaceutical products and biological materials in a safe and efficient manner. This sector plays a crucial role in the healthcare industry by ensuring that medications and vaccines reach their intended destinations in optimal condition. With the ever-increasing global demand for pharmaceutical products, bio-pharma logistics has become an integral part of the supply chain, requiring specialized infrastructure and expertise.

Market Dynamics:

The bio-pharma logistics market is driven by several factors. Firstly, the increasing prevalence of chronic diseases and the growing need for personalized medicine have led to a surge in pharmaceutical research and development activities. This, in turn, has resulted in a higher volume of drugs and biologics being manufactured and distributed, boosting the demand for efficient logistics solutions.

On the other hand, the market also faces certain challenges. The stringent regulatory requirements for the transportation and storage of pharmaceutical products, especially those that require cold chain management, pose a significant restraint. Compliance with these regulations is crucial to maintain product integrity and ensure patient safety, which adds complexity and cost to the logistics process.

However, the market presents lucrative opportunities as well. The rising adoption of technology, such as IoT and blockchain, in tracking and tracing pharmaceutical shipments has improved supply chain visibility and integrity. This has enabled real-time monitoring of temperature-sensitive products, reducing the risk of spoilage and ensuring product quality. Additionally, the growing e-commerce sector has opened up new channels for the distribution of pharmaceutical products, creating a potential market for bio-pharma logistics players.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Key players in the global bio-pharma logistics market are profiled based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies.
  • The key companies covered in this study include DHL, FedEx, UPS, DB Schenker, Kuehne + Nagel, SF Express, Kerry Logistics, Agility Logistics, VersaCold Logistics Services, Marken, Air Canada Cargo, CEVA Logistics, Sofrigam, Nordic Cold Storage, Biocair, United Parcel Service, Cavalier Logistics, LifeConEx, AirBridgeCargo Airlines, and World Courier.
  • The insights from this report would enable marketers and management authorities of companies to make informed decisions regarding product launches, type upgrades, market expansion, and marketing tactics.
  • The global bio-pharma logistics market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders will benefit from the various strategy matrices used in analyzing the global bio-pharma logistics market, which will facilitate ease in decision-making.

Bio-pharma Logistics Market Segmentation:

  • By Type (Revenue, USD Bn, 2021 - 2033)
  • Cold Chain Logistics
  • Non-cold Chain Logistics
  • Others
  • By Temperature Type (Revenue, USD Bn, 2021 - 2033)
  • Frozen
  • Chilled
  • Ambient
  • Others
  • By Service (Revenue, USD Bn, 2021 - 2033)
  • Transportation
  • Warehousing
  • Packaging
  • Others
  • By Application (Revenue, USD Bn, 2021 - 2033)
  • Clinical Trials Logistics
  • Cell & Gene Therapy Logistics
  • Medical Device Logistics
  • Biological Products Logistics
  • Vaccine Logistics
  • Drug Logistics
  • Chemical Logistics
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top companies in Bio-pharma Logistics Market
  • DHL
  • FedEx
  • UPS
  • DB Schenker
  • Kuehne + Nagel
  • SF Express
  • Kerry Logistics
  • Agility Logistics
  • VersaCold Logistics Services
  • Marken
  • Air Canada Cargo
  • CEVA Logistics
  • Sofrigam
  • Nordic Cold Storage
  • Biocair
  • United Parcel Service
  • Cavalier Logistics
  • LifeConEx
  • AirBridgeCargo Airlines
  • World Courier

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Bio-pharma Logistics, By Type
    • Market Bio-pharma Logistics, By Service Type
    • Market Bio-pharma Logistics, By Application
    • Market Bio-pharma Logistics, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
      • Technological advancements in cold chain logistics solutions
    • Restraints
      • High costs associated with logistics services
    • Opportunities
      • Expansion in emerging markets
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Bio-pharma Logistics Market, By Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Cold Chain Logistics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Non-cold Chain Logistics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Bio-pharma Logistics Market, By Service Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Transportation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Warehousing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Packaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Bio-pharma Logistics Market, By Application, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Biologics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Prescribed drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Over-the-Counter medicines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Raw materials and bulk pharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Bio-pharma Logistics Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country 2021 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • DHL
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FedEx
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • UPS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DB Schenker
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kuehne + Nagel
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SF Express
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kerry Logistics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Agility Logistics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • VersaCold Logistics Services
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Marken
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Air Canada Cargo
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CEVA Logistics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sofrigam
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Nordic Cold Storage
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biocair
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • United Parcel Service
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cavalier Logistics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LifeConEx
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • AirBridgeCargo Airlines
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • World Courier
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us